Tenpoint Therapeutics is set to join the US market for drugs to treat presbyopia, taking on rival therapies from AbbVie, Orasis Pharma, and LENZ Therapeutics, after getting FDA approval for its ...
All credit to a newly-minted Palme d'Or-winner for having the courage to step out of their comfort zone, but "Alpha" is an insufferable misfire.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results